Worked in consumer complaint department of a major food manufacturer for over 30+ years. Identified validity of foreign substances in food. Tested new products and raw materials to ensure they met specifications.
Worked in consumer complaint department of a major food manufacturer for over 30+ years. Identified validity of foreign substances in food. Tested new products and raw materials to ensure they met specifications.
less
Latest Comments
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
What an amazing call on AVIR! Your analysis basically predicted its demise. I really think this is worth highlighting because that was a bold call. The stock is in an uptrend but not so fast look at the data!
"While management appears optimistic about the prospect of AT-527 in hospitalized patients, the data tells a different tale. In the chart above, AT-527 can’t seem to get enough of a reduction of viral load from the control.They are measuring clinical outcomes like reduction in hospitalization, but the reality is that, like remdesivir, this drug is just a viral inhibitor and doesn’t have any immunomodulatory properties that could help hospitalized patients with the inflammation that they have which causes respiratory distress. "
Great article. Definately paying attention to the call on TOMDF! It seems like you really dig deep in your analysis.